NCT00822588

Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not

A Prospective, Randomized, Controlled Trial of Retransfusion of Intra-operatively Collected Filtered Whole Blood in Total Hip Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 227 (actual)
• Sponsor: Wellspect HealthCare · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study is a prospective, controlled, randomised and assessor blind study that investigate if the need for bank blood transfusion could be reduced in patients, undergoing primary or revision total hip replacement surgery, who receive their own blood back with the medical device Sangvia. A comparison in need for bank blood will be made between patients that either receive their own blood back or not.

Conditions

• Arthroplasty, Replacement, Hip
• Blood Transfusion
• Blood Transfusion, Autologous

Interventions

Type	Name	Description
DEVICE	Sangvia® System	Sangvia® Intra- and Post-op System

Timeline

• Start date: 2009-05-01
• Primary completion: 2010-06-01
• Completion: 2010-06-01
• First posted: 2009-01-14
• Last updated: 2012-10-04
• Results posted: 2011-05-03

Locations

6 sites across 4 countries: Austria, Netherlands, Norway, Spain